- Poster presentation
- Open Access
Recidivant criminal behaviour and executive dysfunction
© Barbosa and Luis; licensee BioMed Central Ltd. 2008
- Published: 17 April 2008
- Public Health
- Executive Functioning
- Criminal Behaviour
- Male Control
- Global Score
To experimentally test the hypothesis according to which recidivist subjects in non-violent criminal behaviours display an executive deficit, having alterations on prefrontal functioning as neurophysiological substrate.
We applied the Behavioural Assessment of the Dysexecutive Syndrome (BADS) - a battery of assessment of the executive dysfunctions - to an experimental group of 30 male inmates who were recidivist in crimes against property (age= 39,3; s.d..= 9,98), and to a group of 30 male controls (age=32,7; s.d.=11,8), all Caucasian.
Compared to controls, recidivist inmates performed worse in most of the subscales and showed a lower global score, suggesting defective executive functioning.
Avoiding the idea of a frontal “criminogenesis”, and despite the fact that both samples are not very large, the authors seek to present a possible interpretation for certain forms of persistent criminal behaviour, particularly when criminals are resistant to penal measures, in the frame of a defective control over conduct and its consequences.
- Hare R, Frazelle J, Bus J, y Jutai J: Psychopathy and structure of primary mental abilities. Journal of Behavioral Assessment. 1980, 2: 77-88. 10.1007/BF01338924.View ArticleGoogle Scholar
- Marques-Teixeira J: Comportamento criminal: perspectiva biopsicolσgica. 2000, Linda a Velha: Vale & ValeGoogle Scholar
- Wilson B, Evans J, Emslie H, Alderman N, y Burgess P: The Development of an Ecologically Valid Test for Assessing Patients with a Dysexecutive Syndrome. Special number of the Journal of Neuropsychological Rehabilitation. 1998, Psychology PressGoogle Scholar
- Barbosa F: Psicofisiologia do comportamento criminal reincidente: νndices perifιricos autonσmicos. Saïde-Mental. 2001, 3 (3): 19-32.Google Scholar
This article is published under license to BioMed Central Ltd.